Loading…
Merck KGaA is building a single-use manufacturing operation in Wuxi, China, that will be operational in 2018, targeting China's biosimilars market.
“With its eye on China's 'burgeoning' biosimilars market, Merck said it is building a single-use manufacturing operation in Wuxi, China.”fiercepharma.com
Summarized from public sources; check the original articles before acting on it.